Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
5.363 ^DKK	+4.38%		+9.43%	+14.53%

06-12	CS Medica to Boost Denmark Operations With OneMed Partnership	MT
06-11	CS Medica, GP Europe Sign Letter of Intent for Potential Hemp Products Partnership	MT

Presentation Operator MessageOperator (Operator)Good afternoon, and welcome to this financial ...

This article is reserved for subscribers

Signed up already?

Not subscribed yet?

Latest news about CS MEDICA A/S

CS Medica to Boost Denmark Operations With OneMed Partnership	06-12	MT
CS Medica, GP Europe Sign Letter of Intent for Potential Hemp Products Partnership	06-11	MT
CS Medica Advances Spin-off, Listing Plans in Germany for Cannordic Unit	06-10	MT
CS Medica A/S agreed to Spin-Off Cannordic A/S.	06-09	CI
Transcript : CS Medica A/S, H1 2024 Earnings Call, May 23, 2024	05-23
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-17	CI
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	04-30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	04-22	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	04-12
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04-04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	02-21
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	02-20	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	02-02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	01-26	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	12-27	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	12-05
CS Medica A/S Announces Financial Year Change	11-22	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	11-22	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	11-22	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	31/10/23	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	12/10/23	CI
Danske Bank Extends DKK 1.2 Million Credit Line to CS MEDICA	10/10/23	CI
CS Medica A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	13/09/23	CI
CS Medica Secures Denmark Patent for Nasal Spray	30/08/23	MT
Transcript : CS Medica A/S, Q3 2023 Earnings Call, Aug 08, 2023	08/08/23

Chart CS MEDICA A/S

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar